Dr. Stuart D. Schatz, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 7305 Baltimore Avenue, Suite 202, College Park, MD 20740 Phone: 301-277-6100 Fax: 301-277-4005 |
Myeyedr. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 7305 Baltimore Ave Ste 202, College Park, MD 20740 Phone: 301-277-6100 Fax: 301-277-4005 |
Dr. Jiyon Cheng, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 10250 Baltimore Ave, Suite C, College Park, MD 20740 Phone: 301-614-0859 Fax: 301-474-3086 |
Jordan Tyler Oliver, OD Optometrist Medicare: Medicare Enrolled Practice Location: 7305 Baltimore Ave Ste 202, College Park, MD 20740 Phone: 301-277-6100 |
Dr. Stephanie Marie Cathell, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 7305 Baltimore Ave Ste 202, College Park, MD 20740 Phone: 301-277-6100 |
Contact Lens Associates Optometrist Medicare: Not Enrolled in Medicare Practice Location: 7305 Baltimore Avenue, Suite 202, College Park, MD 20740 Phone: 301-277-6100 Fax: 301-277-4005 |
News Archive
Unrecognized atrial fibrillation could be a cause of some wake-up strokes, say researchers who found an increased prevalence of the arrhythmia in patients who had stroke symptoms on waking.
Cambridge Heart, Inc., today announced that results of a clinical study presented at the 29th Annual Scientific Meeting of the Belgian Society of Cardiology in Brussels, Belgium, reinforce the value of the Microvolt T-wave Alternans (MTWA) as an accurate non-invasive test to identify patients at risk of arrhythmic events and sudden cardiac death (SCD).
A major Center that will propel scientific efforts to pinpoint the specific genes involved in causing immune diseases, cancer and other diseases will be opened today at the La Jolla Institute for Allergy & Immunology.
Adolescents who received interpersonal psychotherapy for depression at school-based health clinics had fewer symptoms of depression after 12 to 16 weeks than their peers who received other kinds of psychotherapy at school, according to an article in the June issue of the Archives of General Psychiatry, one of the JAMA/Archives journals.
Transgenomic, Inc. announced today that it has acquired an exclusive worldwide license to Montefiore Medical Center's patent application, "Method of Determining the Sensitivity of Cancer Cells to EGFR Inhibitors including cetuximab, panitumumab and erlotinib".
› Verified 1 days ago